HC
BIO icon

Hosking & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Hosking & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$4.72M Buy
31,333
+2,186
+7% +$313K 0.32% 81
2015
Q1 		$3.94M Sell
29,147
-18,418
-39% -$2.28M 0.28% 84
2014
Q4 		$5.73M Buy
+47,565
New +$5.47M 0.43% 55

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hosking & Co's BIO Position: Q2 2015 in Review

Hosking & Co increased its Bio-Rad Laboratories Class A (BIO) stake by 7.5% in Q2 2015, buying an estimated $313K and bringing the position to 31,333 shares worth $4.72M. The position accounts for 0.32% of the portfolio, ranked #81.

Hosking & Co first reported a position in BIO in Q4 2014 and has held it in 3 quarters since. The position peaked at $5.73M in Q4 2014. 225 funds tracked by Wall St. Rank hold BIO as of Q2 2015.

  • Hosking & Co held 31,333 shares of Bio-Rad Laboratories Class A worth $4.72M as of Q2 2015.
  • Hosking & Co bought 2,186 Bio-Rad Laboratories Class A shares in Q2 2015, an estimated $313K.
  • Bio-Rad Laboratories Class A made up 0.32% of Hosking & Co's portfolio in Q2 2015, its #81 holding.
  • Hosking & Co first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and has held it in 3 quarters since.
  • Hosking & Co's Bio-Rad Laboratories Class A position peaked at $5.73M in Q4 2014.
  • 225 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2015.

Based on Hosking & Co's 13F filing for Q2 2015, filed 13 Aug 2015.